首页> 美国卫生研究院文献>Journal of Virology >Sensitivity to a Nonpeptidic Compound (RPR103611) Blocking Human Immunodeficiency Virus Type 1 Env-Mediated Fusion Depends on Sequence and Accessibility of the gp41 Loop Region
【2h】

Sensitivity to a Nonpeptidic Compound (RPR103611) Blocking Human Immunodeficiency Virus Type 1 Env-Mediated Fusion Depends on Sequence and Accessibility of the gp41 Loop Region

机译:对一种非肽类化合物(RPR103611)的敏感性其阻断人类免疫缺陷病毒1型环境介导的融合取决于gp41环区的序列和可及性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The triterpene RPR103611 is an efficient inhibitor of membrane fusion mediated by the envelope proteins (Env, gp120-gp41) of CXCR4-dependent (X4) human immunodeficiency virus type 1 (HIV-1) strains, such as HIV-1LAI (LAI). Other X4 strains, such as HIV-1NDK (NDK), and CCR5-dependent (R5) HIV-1 strains, such as HIV-1ADA (ADA), were totally resistant to RPR103611. Analysis of chimeric LAI-NDK Env proteins identified a fragment of the NDK gp41 ectodomain determining drug resistance. A single difference at position 91, leucine in LAI and histidine in NDK, apparently accounted for their sensitivity or resistance to RPR103611. We had previously identified a mutation of isoleucine 84 to serine in a drug escape LAI variant. Both I84 and L91 are located in the “loop region” of gp41 separating the proximal and distal helix domains. Nonpolar residues in this region therefore appear to be important for the antiviral activity of RPR103611 and are possibly part of its target. However, another mechanism had to be envisaged to explain the drug resistance of ADA, since its gp41 loop region was almost identical to that of LAI. Fusion mediated by chimeric Env consisting of LAI gp120 and ADA gp41, or the reciprocal construct, was fully blocked by RPR103611. The gp120-gp41 complex of R5 strains is stable, relative to that of X4 strains, and this stability could play a role in their drug resistance. Indeed, when the postbinding steps of ADA infection were performed under mildly acidic conditions (pH 6.5 or 6.0), a treatment expected to favor dissociation of gp120, we achieved almost complete neutralization by RPR103611. The drug resistance of NDK was partially overcome by preincubating virus with soluble CD4, a gp120 ligand inducing conformational changes in the Env complex. The antiviral efficacy of RPR103611 therefore depends on the sequence of the gp41 loop and the stability of the gp120-gp41 complex, which could limit the accessibility of this target.
机译:三萜RPR103611是由CXCR4依赖性(X4)1型人类免疫缺陷病毒(HIV-1)株,例如HIV-1LAI(LAI)的包膜蛋白(Env,gp120-gp41)介导的膜融合的有效抑制剂。其他X4毒株,例如HIV-1NDK(NDK)和CCR5依赖(R5)HIV-1毒株,例如HIV-1ADA(ADA),对RPR103611完全耐药。嵌合LAI-NDK Env蛋白的分析鉴定了NDK gp41胞外域的片段,决定了耐药性。在位置91处的单一差异(LAI中的亮氨酸和NDK中的组氨酸)显然说明了它们对RPR103611的敏感性或耐药性。我们先前已经在药物逃逸LAI变体中鉴定出异亮氨酸84突变为丝氨酸。 I84和L91都位于gp41的“环区”中,将近端和远端螺旋结构域分开。因此,该区域中的非极性残基似乎对RPR103611的抗病毒活性很重要,并且可能是其靶标的一部分。但是,必须设想另一种机制来解释ADA的耐药性,因为其gp41环区与LAI几乎相同。由LAI gp120和ADA gp41组成的嵌合Env介导的融合或可逆构建体被RPR103611完全阻断。相对于X4菌株,R5菌株的gp120-gp41复合物是稳定的,这种稳定性可能在其耐药性中起作用。确实,当ADA感染的后结合步骤是在中等酸性条件(pH 6.5或6.0)下进行的,这种处理有望促进gp120的解离,我们通过RPR103611实现了几乎中和。通过将病毒与可溶性CD4预孵育可以部分克服NDK的耐药性,可溶性CD4是在Env复合物中诱导构象变化的gp120配体。因此,RPR103611的抗病毒效力取决于gp41环的序列和gp120-gp41复合物的稳定性,这可能会限制该靶标的可及性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号